Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system

Journal of Clinical Microbiology

Volumn 52, Issue 3, 2014, Pages 885-889

  Van Der Pol, Barbara ^a,b   Williams, James A ^b   Taylor, Stephanie N ^c   Cammarata, Catherine L ^c   Rivers, Charles A ^a   Body, Barbara A ^d   Nye, Melinda ^d   Fuller, Deanna ^e   Schwebke, Jane R ^a   Barnes, Mathilda ^f   Gaydos, Charlotte A ^f  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d LABORATORY CORPORATION OF AMERICA   (United States)

^e WISHARD HEALTH SERVICES   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FEMALE; FUNGUS CULTURE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; PARASITE CULTIVATION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA SMEAR;

ADULT; AUTOMATION, LABORATORY; DNA, PROTOZOAN; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; SELF ADMINISTRATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINA;

EID: 84896705632     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02966-13     Document Type: Article

References (23)

1. World Health Organization. 2012. Global incidence and prevalence of selected curable sexually transmitted diseases - 2008. World Health Organization, Geneva, Switzerland.
2. Centers for Disease Control and Prevention. 2012. Trichomoniasis: CDC fact sheet. Centers for Disease Control and Prevention, Atlanta, GA.
3. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. 2007. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin. Infect. Dis. 45:1319-1326. http://dx.doi.org/10.1086/522532. (Pubitemid 351411908)
4. Cotch MF, Pastorek JG, II, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360. (Pubitemid 27306585)
5. Hitti J, Nugent R, Boutain D, Gardella C, Hillier SL, Eschenbach DA. 2007. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr. Perinat. Epidemiol. 21:330-337. http://dx.doi .org/10.1111/j.1365-3016.2007.00807.x. (Pubitemid 46905336)
6. Kigozi GG, Brahmbhatt H, Wabwire-Mangen F, Wawer MJ, Serwadda D, Sewankambo N, Gray RH. 2003. Treatment of Trichomonas in pregnancy and adverse outcomes of pregnancy: a subanalysis of a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol. 189:1398-1400. http://dx.doi.org/10.1067/S0002-9378(03) 00777-4. (Pubitemid 37542180)
7. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. 2002. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 34:519-522. http://dx.doi.org/10.1086/338399. (Pubitemid 34112274)
8. Muzny CA, Schwebke Jr. 2013. The clinical spectrum of Trichomonas vaginalis infection and challenges to management. Sex. Transm. Infect. 89:423-425. http://dx.doi.org/10.1136/sextrans-2012-050893.
9. Kissinger P, Adamski A. 2013. Trichomoniasis and HIV interactions: a review. Sex. Transm. Infect. 89:426-433. http://dx.doi.org/10.1136/sextrans- 2012-051005.
10. Mavedzenge SN, Van Der Pol B, Cheng H, Montgomery ET, Blanchard K, de Bruyn G, Ramjee G, van der Straten A. 2010. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex. Transm. Dis. 37:460-466. http://dx.doi.org/10.1097/OLQ.0b013e3181cfcc4b.
11. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH. 2009. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Transm. Dis. 36:11-16. http://dx.doi.org/10.1097/OLQ. 0b013e318186decf.
12. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J. Infect. Dis. 195: 698-702. http://dx.doi.org/10.1086/511278.
13. Guenthner PC, Secor WE, Dezzutti CS. 2005. Trichomonas vaginalisinduced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect. Immun. 73:4155-4160. http://dx.doi.org/10.1128/IAI .73.7.4155-4160.2005. (Pubitemid 40923157)
14. Rendon-Maldonado J, Espinosa-Cantellano M, Soler C, Torres JV, Martinez-Palomo A. 2003. Trichomonas vaginalis: in vitro attachment and internalization of HIV-1 and HIV-1-infected lymphocytes. J. Eukaryot. Microbiol. 50:43-48. http://dx.doi.org/10.1111/j.1550-7408.2003.tb00104.x. (Pubitemid 36333420)
15. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS. 2008. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Infect. Dis. 197:548-554. http://dx.doi.org/10.1086/526496. (Pubitemid 351321532)
16. Kingston MA, Bansal D, Carlin EM. 2003. 'Shelf life' of Trichomonas vaginalis. Int. J. STD AIDS 14:28-29. http://dx.doi.org/10.1258/ 095646203321043228.
17. Stoner KA, Rabe LK, Meyn LA, Hillier SL. 2013. Survival of Trichomonas vaginalis in wet preparation and on wet mount. Sex. Transm. Infect. 89: 485-488. http://dx.doi.org/10.1136/sextrans-2012-051001.
18. Bachmann LH, Hobbs MM, Sena AC, Sobel JD, Schwebke JR, Krieger JN, McClelland RS, Workowski KA. 2011. Trichomonas vaginalis genital infections: progress and challenges. Clin. Infect. Dis. 53(Suppl 3):S160-S172. http://dx.doi.org/10.1093/cid/cir705.
19. Nye MB, Schwebke JR, Body BA. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200:188.e1-188.e7. http://dx.doi.org/10.1016/j.ajog. 2008.10.005.
20. Taylor SN, Van Der Pol B, Lillis R, Hook EW, III, Lebar W, Davis T, Fuller D, Mena L, Fine P, Gaydos CA, Martin DH. 2011. Clinical evaluation of the BD ProbeTec Chlamydia trachomatis Qx amplified DNA assay on the BD Viper system with XTR technology. Sex. Transm. Dis. 38:603-609. http://dx.doi.org/10.1097/ OLQ.0b013e31820a94d2.
21. Martin DH, Nsuami M, Schachter J, Hook EW, III, Ferrero D, Quinn TC, Gaydos C. 2004. Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections. J. Clin. Microbiol. 42: 4749-4758. http://dx.doi.org/10.1128/JCM.42.10.4749-4758.2004. (Pubitemid 39362398)
22. Qu Y, Tan M, Kutner M. 1996. Random effects model in latent class analysis for evaluating accuracy of diagnostic tests. Biometrics 52:797-810. http://dx.doi.org/10.2307/2533043. (Pubitemid 26296059)
23. Hoots BE, Peterman TA, Torrone EA, Weinstock H, Meites E, Bolan GA. 2013. A Trich-y question: should Trichomonas vaginalis infection be reportable? Sex. Transm. Dis. 40:113-116. http://dx.doi.org/10.1097/OLQ.0b013e31827c08c3.